[특허]Localized molecular and ionic transport to and from tissues

Massachusetts Institute of Technology, The General Hospital Corporation

검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
검색연산자

검색도움말
검색연산자	기능	검색시 예
()	우선순위가 가장 높은 연산자	예1) (나노 (기계 \| machine))
공백	두 개의 검색어(식)을 모두 포함하고 있는 문서 검색	예1) (나노 기계) 예2) 나노 장영실
\|	두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색	예1) (줄기세포 \| 면역) 예2) 줄기세포 \| 장영실
!	NOT 이후에 있는 검색어가 포함된 문서는 제외	예1) (황금 !백금) 예2) !image
*	검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색	예) semi*
""	따옴표 내의 구문과 완전히 일치하는 문서만 검색	예) "Transform and Quantization"

과학기술 지식인프라 ScienceON

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

특허 상세정보

MyON담기

내보내기 페이스북 공유 트위터 공유 카카오톡 공유

Localized molecular and ionic transport to and from tissues

특허상세정보
국가/구분	United States(US) Patent 등록
국제특허분류(IPC7판)	A61M-031/00
미국특허분류(USC)	604/500; 604/068; 604/022; 128/898
출원번호	US-0878155 (2001-06-07)
발명자 / 주소	Weaver, James C. Anderson, R. Rox Herndon, Terry O Gowrishankar, T. R. Gift, Elizabeth A. Gonzalez, Salvador
출원인 / 주소	Massachusetts Institute of Technology, The General Hospital Corporation
인용정보	피인용 횟수 : 70 인용 특허 : 17

초록
▼

대표
청구항
▼

The present invention relates to methods and devices used for the formation of microconduits in a tissue. The term "microconduit" refers to a small opening, channel, or hole into, or through, a tissue, that allows transfer of materials by liquid flow, and by electrophoresis, the microconduit being formed upon impact of a plurality of accelerated microparticles with the surface of the tissue. A method is described for forming at least one microconduit in tissue including the steps of: accelerating a plurality of microparticles to a velocity that causes the microparticles to penetrate a region of tissue surface upon impingement of the microparticles on the tissue surface; and directing the microparticle towards the region of tissue surface, thereby causing the microparticles to penetrate the tissue and form a microconduit in the tissue. According to an embodiment, microparticles are accelerated by being hit with a moving, solid surface. In another embodiment, microparticles are accelerated by a flowing gas or liquid. Also described are methods and devices for using microconduits to deliver therapeutic molecules and ions into tissue, or for extraction of chemical analytes out of tissue. Also described is a method of nail piercing to accommodate jewelry. mono-alkoxy polyethylene glycol mono(meth) acrylates, including mono-methoxy triethylene glycol mono (meth) acrylate, mono-meth oxy tetraethylene glycol mono (meth) acrylate, polyethylene glycol mono (meth) acrylate; other hydrophilic acrylates such as 2-hydroxyethylmethacrylate, glycerylmethacrylate; acrylic acid and its salts; acrylamide and acrylonitrile; acrylamidomethylpropane sulfonic acid and its salts, cellulose, cellulose derivatives such as methyl cellulose ethyl cellulose, carboxymethyl cellulose, cyanoethyl cellulose, cellulose acetate, polysaccharides such as amylose, pectin, amylopectin, alginic acid, and crosslinked heparin. 3. The catheter of claim 1, wherein the first layer is cross-linked to the polymeric elongate member by the application of ultraviolet radiation. 4. The catheter of claim 1, wherein the second layer is cross-linked to the first layer by the application of ultraviolet radiation. 5. The catheter of claim 1, wherein the external coating is hydrophilic. 6. The catheter of claim 1, wherein the flexible elongate shaft varies in stiffness, having a proximal portion of a relatively high stiffness and a distal portion of a relatively low stiffness, with an intermediate portion having a stiffness between that of the proximal portion and that of the distal portion. 7. The catheter of claim 1, wherein the flexible elongate shaft includes a braided support member. 8. The catheter of claim 1, wherein the polymeric elongate member is comprised of a material selected from the group consisting of polyethylene, polypropylene, polyurethane, a block copolymer of polyamide, silicone, Nylon, polyvinyl chloride, polyethylene terepthalate, polyester elastomer tubing, a polymer outer core with a metallic mesh inner core, and laminates thereof. 9. The catheter of claim 1, wherein the polymeric elongate member is doped with a radiopaque metallic material. covalent bond, where R2is hydrogen, alkyl, aralkyl, aryl, hydroxy(C2-10)alkyl, amino(C2-10)alkyl, monoalkylamino(C2-10)alkyl, dialkylamino(C2-10)alkyl or carboxyalkyl; Het is selected from the group consisting of where R3,R4and R5are independently hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, trifluoromethyl, halogen, hydroxyalkyl, cyano, nitro, carboxamido, alkoxycarbonylmethyl, carboxymethyl, --CO2Rx,--CH2ORxor --ORx,where Rx,in each instance, is independently one of hydrogen, alkyl or cycloalkyl wherein said alkyl or cycloalkyl groups may optionally have one or more unsaturations; R6is hydrogen, alkyl, aralkyl, aryl, cyano(C2-10)alkyl, hydroxy(C2-10)alkyl, alkoxy(C2-10)alkyl, mono- and di-alkylamino(C2-10)alkyl, or carboxyalkyl; R7is hydrogen, C1-4alkyl, or C2-4alkenyl; R8is hydrogen, alkyl, alkenyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylamino (C2-10)alkyl, dialkylamino(C2-10)alkyl or carboxyalkyl; R12,R13,R14and R15are independently hydrogen, alkyl, aralkyl, aryl, hydroxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl or carboxyalkyl; or R12and R13are taken together to form --(CH2)y--, where y is 2 to 7, while R14and R15are defined as above; or R14and R15are taken together to form --(CH2)q--, where q is 2 to 7, while R12and R13are defined as above; or R12and R14are taken together to form --(CH2)r--, where r is 0 or 1 to 7, while R13and R15are defined as above; X is oxygen or NR9, where R9is hydrogen, alkyl, cycloalkyl or aryl, wherein said alkyl, cycloalkyl or aryl can be optionally substituted with amino, monoalkylamino, dialkylamino, alkoxy, hydroxy, carboxy, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, aryl, heteroaryl, acylamino, cyano or trifluoromethyl; Ra,Rband Rcare independently hydrogen, alkyl, hydroxy, alkoxy, aryloxy, aryloxy, alkoxycarbonyloxy, cyano or --CO2Rw,where Rwis alkyl, cycloalkyl, phenyl, benzyl, where Rdand Reare independently hydrogen, C1-6alkyl, C2-6alkenyl or phenyl, Rfis hydrogen, C1-6alkyl, C2-6alkenyl or phenyl, Rgis hydrogen, C1-6alkyl, C2-6alkenyl or phenyl, and Rhis aralkyl or C1-6alkyl; n is from zero to 8; and m is from zero to 6. 2. The device of claim 1, wherein R1is C6-10ar(C1-4) alkyl, C6-10aryl, C4-7cycloalkyl(C1-4)alkyl, heterocycle or heterocyclo(C1-4)alkyl, any of which is optionally substituted; and wherein the heterocycle of said heterocycle or heterocyclo(C1-4)alkyl is a 5- to 7-member mono-cyclic, or 9- to 10-member bi-cyclic heterocyclic ring that is saturated or unsaturated, and contains 1 to 3 heteroatoms selected from N, O and S. 3. The device of claim 2, wherein R1is C6-10ar(C1-4) alkyl, C6-10aryl, C4-7cycloalkyl(C1-4)alkyl, any of which is optionally substituted by 1-5 of hydroxy, nitro, trifluoromethyl, halogen, C1-6alkyl, C2-6alkenyl, C6-10aryl, C1-6alkoxy, C6-10ar(C1-6)alkoxy, C1-6aminoalkyl, C1-6aminoalkoxy, amino, mono(C1-4)alkylamino, di(C 1-4)alkylamino, C2-6alkylcarbonylamino, C2-6alkoxycarbonylamino, C2-6alkoxycarbonyl, carboxy, C1-6hydroxyalkyl, C2-6hydroxyalkoxy, (C1-6)alkoxy(C2-6)alkoxy, mono- and di-C1-4alkylamino (C2-6)alkoxy, C2-10mono(carboxyalkyl)amino, bis(C2-10carboxyalkyl)amino, C6-14ar(C1-6) alkoxycarbonyl, C2-6alkynylcarbonyl, C1-6alkylsulfonyl, C2-6alkenylsulfonyl, C2-6alkynylsulfonyl, C6-10arylsulfonyl, C6-10ar(C1-6) alkylsulfonyl, C1-6alkylsulfinyl, C1-6alkylsulfonamido, C6-10arylsulfonamido, C6-10ar(C1-6)alkylsulfonamido, amidino, guanidino, C1-6alkyliminoamino, formyliminoamino, C2-6carboxyalkoxy, C2-6carboxyalkyl, carboxyalkylamino, cyano, trifluoromethoxy, or perfluoroethoxy. 4. The device of claim 1, wherein Het is selected from the group consisting of: where R3,R4and R5are independently hydrogen, C1-4alkyl, C3-7cycloalkyl, C6-14aryl, C6-10ar(C1-4)alkyl, trifluoromethyl, halogen, hydroxyalkyl, cyano, nitro, carboxamido, carboxy, alkoxycarbonyl, carboxymethyl, alkoxycarbonylmethyl, alkoxy, hydroxy, or cycloalkyloxycarbonyl. 5. The device of claim 4, wherein R3,R4and R5are independently hydrogen, methyl, ethyl, propyl, chloro, bromo, trifluoromethyl, hydroxymethyl, methoxy, ethoxy, carboxamido, nitro, phenyl, cyclopropyl, hydroxy, isopropyl, methoxycarbonyl, ethoxycarbonyl and benzyl. 6. The device of claim 1, wherein R3and R4groups are independently hydrogen, C1-12alkyl, or C2-6alkenyl. 7. The device of claim 6, wherein R3and R4are hydrogen. 8. The device of claim 1, wherein R5is hydrogen, halogen, C1-5alkyl, C3-6alkenyl, C3-5cycloalkyl, trifluoromethyl, or C1-4alkoxy. 9. The device of claim 1, wherein Het is: wherein R3and R4are independently selected to be hydrogen or methyl, and R5is selected from the group consisting of hydrogen, methyl, ethyl, propenyl, allyl, propyl, isopropyl, butyl, R-sec-butyl, S-sec-butyl, isobutyl, 1-pentyl, R-2-pentyl, S-2-pentyl, 3-pentyl, S-1-(2-methyl)-butyl, R-2-(3-methyl)-butyl, 1-(3-methyl)-butyl, R-1-(2-methyl)-butyl, cyclopentyl, 2-pyrrolyl, 3-pyrrolyl, 1-hexyl, S-2-hexyl, R-2-hexyl, R-3-hexyl, and S-3-hexyl. 10. The device of claim 9, wherein R5is hydrogen, methyl, ethyl, propyl or isopropyl. 11. The device of claim 1, wherein Z is --SO2-- or a covalent bond. 12. The device of claim 1, wherein R7is hydrogen. 13. The device of claim 1, wherein X is oxygen. 14. The device of claim 1, wherein X is NR9. 15. The device of claim 1, wherein R9is hydrogen or C1-6alkyl, optionally substituted by one, two or three of amino, monoalkylamino, dialkylamino, alkoxy, hydroxy, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, carboalkoxy, phenyl, cyano, trifluoromethyl, acetylamino, pyridyl, thiophenyl, furyl, pyrrolyl or imidazolyl. 16. The device of claim 1, wherein R9is hydrogen, methyl, ethyl, propyl, n-butyl, benzyl, phenethyl, 2-hydroxyethyl, 3-hydroxypropyl, 4-hydroxybutyl, carboxymethyl or carboxyethyl. 17. The device of claim 1, wherein R8is hydrogen, C1-6alkyl or C6-10aryl (C1-6)alkyl. 18. The device of claim 1, wherein R12,R13,R14and R15are independently one of hydrogen, C1-6alkyl, C6-10ar(C1-6)alkyl, C6-10aryl, C2-10hydroxyalkyl or C2-7carboxyalkyl. 19. The device of claim 18, where

이 특허에 인용된 특허 (17)

이 특허를 인용한 특허 피인용횟수: 70

IPC 상위 출원인

내보내기

상세정보
내보내기 구분	파일저장 인쇄 메일전송
구성항목	관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표IPC 관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 공고번호, 공고일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표출원인, 출원인국적, 출원인주소, 발명자, 발명자E, 발명자코드, 발명자주소, 발명자 우편번호, 발명자국적, 대표IPC, IPC코드, 요약, 미국특허분류, 대리인주소, 대리인코드, 대리인(한글), 대리인(영문), 국제공개일자, 국제공개번호, 국제출원일자, 국제출원번호, 우선권, 우선권주장일, 우선권국가, 우선권출원번호, 원출원일자, 원출원번호, 지정국, Citing Patents, Cited Patents
저장형식	Text(ASCII format) Excel format PIAS분석(.xls)
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	> 총 건의 자료가 검색되었습니다. > 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) > 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. > 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) > 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오 > ~ > Text(ASCII format) Excel format

과학기술 지식인프라 ScienceON

ScienceON Chatbot

연합인증

특허 상세정보

Localized molecular and ionic transport to and from tissues

초록
▼

대표
청구항
▼

이 특허에 인용된 특허 (17)

이 특허를 인용한 특허 피인용횟수: 70

IPC 상위 출원인

과제정보

상세정보조회

원문조회

IPC 상세정보(version : 201201)

연구과제 성과물(0)

참여연구원의 다른 문헌(0)

처리중입니다.

잠시만 기다려주세요.

ScienceON Chatbot

연합인증

특허 상세정보

Localized molecular and ionic transport to and from tissues

초록 ▼

대표청구항 ▼

이 특허에 인용된 특허 (17)

이 특허를 인용한 특허 피인용횟수: 70

IPC 상위 출원인

과제정보

상세정보조회

원문조회

IPC 상세정보(version : 201201)

연구과제 성과물(0)

참여연구원의 다른 문헌(0)

처리중입니다.

잠시만 기다려주세요.

초록
▼

대표
청구항
▼